| Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) (NCT05735158) | Krystal Biotech, Inc. | 2023-03-01 |
| A Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT05741021) | Shandong New Time Pharmaceutical Co., LTD | 2023-03-01 |
| Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients (NCT03932318) | Actinium Pharmaceuticals | 2023-03-01 |
| Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast Cancer (NCT05726175) | West China Hospital | 2023-03-01 |
| Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection (NCT05720559) | Liaoning Cancer Hospital & Institute | 2023-03-01 |
| Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease (NCT05373004) | Omar Tarek Elfarargi | 2023-03-01 |
| A Trial Exploring the Opportune Administration of Nab-paclitaxel in the First Line Treatment, Camrelizumab Combined With Nab-paclitaxel and Famitinib, of TNBC. (NCT05670925) | Fudan University | 2023-03-01 |
| Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients (NCT05771181) | Fudan University | 2023-03-01 |
| Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis (NCT05555303) | Rwanda Biomedical Centre | 2023-03-01 |
| Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric Cancer (NCT05720533) | Tianjin Medical University Cancer Institute and Hospital | 2023-03-01 |
| Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau (NCT05728736) | Brendan Lucey | 2023-03-01 |
| Real-time Margin Assessment in Head and Neck Cancer (NCT05499065) | University Medical Center Groningen | 2023-03-01 |
| Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy (NCT04965311) | OHSU Knight Cancer Institute | 2023-03-01 |
| Pre-operative Steroids in CRSsP (NCT05095961) | Loma Linda University | 2023-03-01 |
| A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis (NCT05349760) | AmMax Bio, Inc. | 2023-03-01 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B) (NCT05573555) | Pfizer | 2023-03-01 |
| Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML (NCT05805098) | The First Affiliated Hospital of Soochow University | 2023-03-01 |
| Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer (NCT05736952) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2023-03-01 |
| Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain (NCT04593329) | EMS | 2023-03-01 |
| Colostrum Supplements Effect on the Physical Performance and Cognitive Function (NCT06007430) | Al-Mustafa University College | 2023-03-01 |
| A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma (NCT05456256) | Lantern Pharma Inc. | 2023-03-01 |
| Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer (NCT05765877) | Pingping Song | 2023-03-01 |
| Efficacy and Safety of BMSCs (CG-BM1) for ACLF Patients (NCT06740149) | Sun Yat-sen University | 2023-03-01 |
| Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy (NCT05585580) | Qilu Hospital of Shandong University | 2023-03-01 |
| The Use of Photobiomodulation in the Treatment of Oral Complaints of Long COVID-19.A Randomized Controlled Trial. (NCT05760092) | University of Nove de Julho | 2023-03-01 |
| ASURE: Alzheimer Study Using oRal Edaravone (NCT05323812) | Treeway B.V. | 2023-03-01 |
| Uterus Transplantation to Treat Infertility (NCT05646992) | Johns Hopkins University | 2023-03-01 |
| Acute Concussion and Melatonin (NCT04731974) | Children's National Research Institute | 2023-03-01 |
| Study of TP-04 in Participants With Papulopustular Rosacea (NCT05838170) | Tarsus Pharmaceuticals, Inc. | 2023-03-01 |
| Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas (NCT05583149) | Patrick C. Johnson, MD | 2023-03-01 |
| Krill Oil and Metformin in Women With PCOS and Metabolically Unhealthy Obesity (NCT07604870) | Firat University | 2023-03-01 |
| A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer (NCT05769725) | RenJi Hospital | 2023-03-01 |
| The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression (NCT05762458) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-02-28 |
| A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E Mutation (NCT05641493) | Shanghai Henlius Biotech | 2023-02-28 |
| A Study Evaluation the Safety and Efficacy of Hormone Replacement Therapy With North Star Compared to Levothyroxine in Patients With Primary Hypothyroidism (NCT05712421) | Neuvosyn Laboratories, LLC | 2023-02-28 |
| SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC (NCT05747716) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2023-02-28 |
| Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts (NCT05799157) | Veradermics, Inc. | 2023-02-28 |
| An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus (NCT05798117) | Novartis Pharmaceuticals | 2023-02-28 |
| Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma (NCT05715931) | Yu jiren | 2023-02-28 |
| Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age (NCT05727215) | PT Bio Farma | 2023-02-28 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients (NCT05517603) | AnnJi Pharmaceutical Co., Ltd. | 2023-02-28 |
| Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine (NCT05354024) | Butantan Institute | 2023-02-28 |
| Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) (NCT05593614) | AlgoTherapeutix | 2023-02-28 |
| Fenofibrate in Ulcerative Colitis (NCT05753267) | Tanta University | 2023-02-28 |
| Sublingual Dexmedetomidine for Treating Opioid Withdrawal (NCT05712707) | New York State Psychiatric Institute | 2023-02-28 |
| A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis (NCT05721573) | Abcuro, Inc. | 2023-02-28 |
| APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors (NCT05701306) | Ascentage Pharma Group Inc. | 2023-02-28 |
| A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus (NCT05759897) | Shandong Suncadia Medicine Co., Ltd. | 2023-02-28 |
| Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors (NCT05651022) | Indaptus Therapeutics, Inc | 2023-02-28 |
| Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD (NCT05784779) | 1Globe Biomedical Co., Ltd. | 2023-02-28 |
| Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma (NCT05516628) | National Cancer Centre, Singapore | 2023-02-28 |
| Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. (NCT05201066) | Novartis Pharmaceuticals | 2023-02-28 |
| NAD Supplementation and Vascular Health in PAD (NCT06534944) | University of Oklahoma | 2023-02-27 |
| A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) (NCT05668741) | Vertex Pharmaceuticals Incorporated | 2023-02-27 |
| DAOIB for the Treatment of Brain Fog (NCT05764538) | Chang Gung Memorial Hospital | 2023-02-27 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia (NCT05763550) | Haisco Pharmaceutical Group Co., Ltd. | 2023-02-27 |
| Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) (NCT05695378) | Kainos Medicine Inc. | 2023-02-27 |
| DeMONSTRATE-TB Study in Ethiopia (NCT06719193) | Management Sciences for Health | 2023-02-27 |
| Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients (NCT05933031) | HK inno.N Corporation | 2023-02-27 |
| A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer (NCT05226663) | M.D. Anderson Cancer Center | 2023-02-27 |
| Evaluation of the Walk With Ease Program for Fall Prevention (NCT05693025) | Iowa State University | 2023-02-27 |
| Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND) (NCT05565833) | University of Virginia | 2023-02-27 |
| Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis (NCT06800157) | Shanghai Longwood Biopharmaceuticals Co., Ltd. | 2023-02-27 |
| Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients (NCT05300282) | Fondazione Italiana Linfomi - ETS | 2023-02-27 |
| A Study of TL-925 as a Treatment for Dry Eye Disease (NCT05745064) | Telios Pharma, Inc. | 2023-02-27 |
| Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice (NCT05694013) | Hoffmann-La Roche | 2023-02-27 |
| A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis (NCT05695950) | Lakefront Biotherapeutics NV | 2023-02-27 |
| Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T (NCT05760599) | Shi Ming | 2023-02-27 |
| Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) (NCT05683249) | Neurocentria, Inc. | 2023-02-25 |
| Splanchnic Venous Capacitance in Postural Tachycardia Syndrome (NCT05375968) | Vanderbilt University Medical Center | 2023-02-25 |
| Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia (NCT03066739) | University of California, Irvine | 2023-02-25 |
| Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients (NCT05824169) | GeneCradle Inc | 2023-02-25 |
| Perioperative Nitric Oxide Prevents Acute Kidney Injury in Cardiac Surgery Patients With Chronic Kidney Disease (NCT05757557) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2023-02-25 |
| Does Alpha-ketoglutarate Supplementation Lower BiologicaL agE in Middle- Aged Adults? (NCT05706389) | National University of Singapore | 2023-02-24 |
| Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (NCT05346848) | Institut Bergonié | 2023-02-24 |
| A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection (NCT05467553) | National Taiwan University Hospital | 2023-02-24 |
| A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy (NCT05039736) | M.D. Anderson Cancer Center | 2023-02-24 |
| The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning (NCT05946083) | University of Minho | 2023-02-24 |
| A Study of SHR6508 in Secondary Hyperparathyroidism (NCT05663411) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-02-24 |
| Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer (NCT05745363) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-02-24 |
| A Phase II Study of Rituximab, Chidamide, Zanubrutinib-induced and CHOP Therapy (NCT05527912) | Sun Yat-sen University | 2023-02-24 |
| Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma (NCT05765084) | University Hospital, Antwerp | 2023-02-24 |
| Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy (NCT06018558) | Ocugen | 2023-02-23 |
| Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients (NCT05661851) | Johnson & Johnson Vision Care, Inc. | 2023-02-23 |
| A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome (NCT05027945) | National Cancer Institute (NCI) | 2023-02-23 |
| Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases (NCT05704647) | M.D. Anderson Cancer Center | 2023-02-23 |
| A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant (NCT05447663) | Novartis Pharmaceuticals | 2023-02-23 |
| IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors (NCT05699811) | Chinese PLA General Hospital | 2023-02-23 |
| TAP Block vs Spinal Orphine for Postoperative Caesarean Section Analgetics (NCT06089200) | Universitas Padjadjaran | 2023-02-23 |
| A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype (NCT05643495) | Vertex Pharmaceuticals Incorporated | 2023-02-23 |
| BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation (NCT05622123) | Radboud University Medical Center | 2023-02-23 |
| VS-6766+Abema+Fulv in Met HR+/HER- BC (NCT05608252) | Adrienne G. Waks | 2023-02-23 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) (NCT05548127) | Pfizer | 2023-02-23 |
| Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors (NCT05194397) | Children's Hospital of Philadelphia | 2023-02-23 |
| Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma (NCT05394337) | M.D. Anderson Cancer Center | 2023-02-23 |
| Intravitreal Topotecan in the Repair of Rhegmatogenous Retinal Detachment with Proliferative Vitreoretinopathy (NCT05523869) | Unity Health Toronto | 2023-02-23 |
| SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (NCT05731518) | Biocity Biopharmaceutics Co., Ltd. | 2023-02-23 |
| Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis (NCT05182749) | Intralytix, Inc. | 2023-02-23 |
| Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness (NCT06254560) | Institute of Hematology & Blood Diseases Hospital, China | 2023-02-23 |
| Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer (NCT04756765) | Stanford University | 2023-02-23 |